Stocktoria
Metagenomi Therapeutics, Inc. MGX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-09
Metagenomi Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 420,242 | $1.7M | 1.12% |
| RENAISSANCE TECHNOLOGIES LLC | 742,400 | $883,456 | 1.97% |
| TWO SIGMA INVESTMENTS, LP | 513,701 | $611,304 | 1.37% |
| MILLENNIUM MANAGEMENT LLC | 114,025 | $135,690 | 0.3% |
| CITADEL ADVISORS LLC | 17,851 | $21,243 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.